• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

SSRI use during pregnancy not linked to increased risk of autism

bys25qthea
December 19, 2013
in Chronic Disease, Obstetrics, Pediatrics, Psychiatry
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. Serotonin selective reuptake inhibitors (SSRIs) during pregnancy did not increase the risk of autism spectrum disorder in offspring.   

Evidence Rating Level: 2 (Good) 

Study Rundown: Serotonin is a neurotransmitter that has been shown to influence neural development in animal studies. A recent small case-control study demonstrated that serotonin selective reuptake inhibitor (SSRI) use during pregnancy might increase the risk of autism spectrum disorder (ASD) in offspring. This finding was made plausible by the fact that SSRIs are known to cross the placenta.

In this recent large nationwide retrospective cohort study, there was no difference in the risk of ASD in offspring when comparing pregnant women who used SSRIs during pregnancy versus those who did not. This study extracted information from a nationwide Danish database and followed children from birth to up to 10 years of age, which makes this study larger and with lengthier follow up as compared to previous case-control studies.

However, there were also several confounding factors identified by this study as seen by difference between exposed versus non-exposed cohorts which included the psychiatric diagnosis indicating SSRIs, use of other psychiatric medications and self-reported smoking during pregnancy. Another limitation is that this study focused only on data collected from one nation and prior studies have shown that the rate of SSRI use during pregnancy varies between countries, thus the results may not be as generalizable. Future studies should revolve around examining the above-mentioned confounding factors (during pregnancy) on the future risk of ASD in offspring.

Click to read the study, published today in NEJM

RELATED REPORTS

Selective serotonin reuptake inhibitor use may be associated with reduced mortality from COVID-19 infection

Novel preemptive intervention effective in reducing autism spectrum disorder severity and rate of diagnosis

Exercise may enhance executive function among youth with autism spectrum disorder

In-Depth [retrospective cohort]: This study involved 626,875 live births/pregnancies from a nationwide Danish study over a span of 9 years. The pregnancy patients were divided into two cohorts (SSRI-exposed during pregnancy versus non-exposed during pregnancy) and their offspring were followed until the study’s end date or up to 10 years of age. The median age at diagnosis of ASD was 5.6 years. Exposure to SSRI was defined as during the period 4 weeks before the beginning of pregnancy through to delivery. Using the non-SSRI exposed group as reference, those who used SSRIs during pregnancy had an adjusted rate ratio of 1.20 (95% CI 0.90-1.61) and those who used SSRIs 2 years to 6 months before but not during pregnancy had a rate ratio of 1.46 (95% CI 1.17-1.81).

By Jonathan Liu, MD and Xu Gao

More from this author: Combo antifungal therapy most effective treatment for cryptococcal meningitis, Rhinovirus, genes may interact to increase risk of childhood asthma, Functional MRI map for physical pain identified Glutamine and antioxidant supplementation provide no benefit for critically-ill patients New Hepatitis C virus (HCV) treatment effective  

© 2012-2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: autismSSRI
Previous Post

Intranasal oxytocin may improve sociocommunicational deficits in autism

Next Post

Quadrivalent influenza vaccine efficacious in children

RelatedReports

Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Infectious Disease

Selective serotonin reuptake inhibitor use may be associated with reduced mortality from COVID-19 infection

November 20, 2021
Early language exposure is predictive of language skills and IQ in school-age children
Chronic Disease

Novel preemptive intervention effective in reducing autism spectrum disorder severity and rate of diagnosis

October 6, 2021
Quick Take: Association of Prenatal Exposure to Air Pollution with Autism Spectrum Disorder
Pediatrics

Exercise may enhance executive function among youth with autism spectrum disorder

October 4, 2021
Adolescents’ muscle strength associated with lower cardiometabolic risk
Wellness

Wellness Check: Exercise

September 30, 2021
Next Post
Influenza vaccine associated with lower risk of major cardiovascular events

Quadrivalent influenza vaccine efficacious in children

Low diastolic blood pressure associated with higher mortality in chronic kidney disease

Updated JNC 8 guidelines for antihypertensive drugs released

Periodontitis therapy not improving HbA1C levels in type II diabetes patients

Periodontitis therapy not improving HbA1C levels in type II diabetes patients

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Stereotactic body radiotherapy as a state of the art treatment option in inoperable non-small cell lung cancer [Classics Series]
  • Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers
  • APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.